NCT00771680View on ClinicalTrials.gov

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

10,408

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Start dose and frequency at the discretion of the physician following clinical practice

DRUG

biphasic insulin aspart 30

Start dose and frequency at the discretion of the physician following clinical practice

DRUG

insulin aspart

Start dose and frequency at the discretion of the physician following clinical practice

Trial Locations (2)

119330

Novo Nordisk Investigational Site, Moscow

252030

Novo Nordisk Investigational Site, Kiev

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY